1. 1318. Pharmacokinetics and Safety of Cefepime-Taniborbactam (formerly Cefepime/VNRX-5133) in Subjects with Renal Impairment. (31st December 2020) Authors: Geibel, Brooke; Dowell, James A; Marbury, Thomas C; Smith, William; McGovern, Paul C; Richards, Cynthia; Henkel, Tim Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 982. Effect of Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin. (4th December 2021) Authors: Huguet, Jade; Ong, Voon; Sandison, Taylor; Melara, Rebeca M; Marbury, Thomas C; Jandourek, Alena; Flanagan, Shawn Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S582 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Single-Dose Pharmacokinetics and Safety of Daclatasvir in Subjects with Renal Function Impairment. Issue 5 (July 2015) Authors: Garimella, Tushar; Wang, Reena; Luo, Wen-Lin; Hwang, Carey; Sherman, Diane; Kandoussi, Hamza; Marbury, Thomas C; Alcorn, Harry; Bertz, Richard; Bifano, Marc Journal: Antiviral therapy Issue: Volume 20:Issue 5(2015) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The Effect of Hepatic Impairment on the Pharmacokinetics of Asunaprevir, an HCV NS3 Protease Inhibitor. Issue 1 (January 2015) Authors: Eley, Timothy; He, Bing; Chang, Ih; Colston, Elizabeth; Child, Michael; Bedford, William; Kandoussi, Hamza; Pasquinelli, Claudio; Marbury, Thomas C; Bertz, Richard J Journal: Antiviral therapy Issue: Volume 20:Issue 1(2015) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗